The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Metindol     2-[1-(4- chlorophenyl)carbonyl-5- methoxy-2...

Synonyms: Artracin, Artrivia, Indocid, Indocin, Osmosin, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of indomethacin

 

High impact information on indomethacin

  • The fall in single nephron GFR (SNGFR, nl.min-1) with increasing LH perfusion was unchanged after vehicle (10.9 +/- 2.8-11.2 +/- 0.8) but was blunted (P less than 0.05) by 45-55% in rats given indo (13.9 +/- 1.2-6.2 +/- 2.2) or UK (12.8 +/- 2.1-7.0 +/- 1.5) [6].
  • Indo and perhaps other NSAIDs that enter the bile may damage the mucosa, not by a direct action, but by competing for the available protective PC molecules [7].
  • Neither the rise in IL-6 nor the activation of signal transducer and activator of transcription-3 (STAT3) that is seen during liver regeneration is inhibited by indocin or the selective COX antagonists [8].
  • In contrast, indocin treatment prevents the activation of CREB by phosphorylation that occurs during hepatic regeneration [8].
  • In accordance with our hybridization results, an increase in IL-1 activity was obtained when eosinophils were stimulated with LPS and treated with indomethacine [9].
 

Chemical compound and disease context of indomethacin

 

Biological context of indomethacin

 

Anatomical context of indomethacin

 

Associations of indomethacin with other chemical compounds

 

Gene context of indomethacin

 

Analytical, diagnostic and therapeutic context of indomethacin

References

  1. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins. Eliopoulos, G.M., Moellering, R.C. Ann. Intern. Med. (1982) [Pubmed]
  2. Mezlocillin-induced thrombocytopenia. Gharpure, V., O'Connell, B., Schiffer, C.A. Ann. Intern. Med. (1993) [Pubmed]
  3. Acute interstitial nephritis associated with mezlocillin, nafcillin, and gentamicin treatment for Pseudomonas infection. Cushner, H.M., Copley, J.B., Bauman, J., Hill, S.C. Arch. Intern. Med. (1985) [Pubmed]
  4. Aztreonam susceptibility testing. A retrospective analysis. Parry, M.F. Am. J. Med. (1990) [Pubmed]
  5. Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillin. Jones, P.G., Strother, S.V., Rolston, K.V., Fainstein, V., Bodey, G.P. Arch. Intern. Med. (1986) [Pubmed]
  6. Modulating role for thromboxane in the tubuloglomerular feedback response in the rat. Welch, W.J., Wilcox, C.S. J. Clin. Invest. (1988) [Pubmed]
  7. Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats. Barrios, J.M., Lichtenberger, L.M. Gastroenterology (2000) [Pubmed]
  8. Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Rudnick, D.A., Perlmutter, D.H., Muglia, L.J. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  9. Murine eosinophils and IL-1: alpha IL-1 mRNA detection by in situ hybridization. Production and release of IL-1 from peritoneal eosinophils. Del Pozo, V., De Andres, B., Martin, E., Maruri, N., Zubeldia, J.M., Palomino, P., Lahoz, C. J. Immunol. (1990) [Pubmed]
  10. Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure. Rodondi, L.C., Flaherty, J.F., Schoenfeld, P., Barriere, S.L., Gambertoglio, J.G. Clin. Pharmacol. Ther. (1989) [Pubmed]
  11. CI-867, a new semisynthetic penicillin: in vitro studies. Weaver, S.S., Bodey, G.P. Antimicrob. Agents Chemother. (1980) [Pubmed]
  12. Comparative penetration of azlocillin and mezlocillin into cerebrospinal fluid of normal rabbits and rabbits with experimentally induced Pseudomonas aeruginosa meningitis. Hodges, G.R., Worley, S.E. Antimicrob. Agents Chemother. (1982) [Pubmed]
  13. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Boyce, J.M., Opal, S.M., Potter-Bynoe, G., LaForge, R.G., Zervos, M.J., Furtado, G., Victor, G., Medeiros, A.A. Antimicrob. Agents Chemother. (1992) [Pubmed]
  14. Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis. Levison, M.E., Kobasa, W.D. Antimicrob. Agents Chemother. (1984) [Pubmed]
  15. Mezlocillin pharmacokinetics in renal impairment. Aronoff, G.R., Sloan, R.S., Luft, F.C., Nelson, R.L., Maxwell, D.R., Kleit, S.A. Clin. Pharmacol. Ther. (1980) [Pubmed]
  16. Nonlinear mezlocillin kinetics due to dose-dependent metabolism. Gundert-Remy, U., Hildebrandt, R., Stiehl, A., Weber, E. Clin. Pharmacol. Ther. (1983) [Pubmed]
  17. Pharmacokinetics of the acyclureidopenicillins piperacillin and mezlocillin in the postpartum patient. Martens, M.G., Faro, S., Feldman, S., Cotton, D.B., Dorman, K., Riddle, G.D. Antimicrob. Agents Chemother. (1987) [Pubmed]
  18. Comparison of the effects of mezlocillin, carbenicillin, and placebo on normal hemostasis. Ballard, J.O., Barnes, S.G., Sattler, F.R. Antimicrob. Agents Chemother. (1984) [Pubmed]
  19. Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo). Poplawski, J., Lozowicka, B., Dubis, A.T., Lachowska, B., Witkowski, S., Siluk, D., Petrusewicz, J., Kaliszan, R., Cybulski, J., Strzałkowska, M., Chilmonczyk, Z. J. Med. Chem. (2000) [Pubmed]
  20. Pharmacokinetics and bacteriological efficacy of mezlocillin in experimental Escherichia coli and Listeria monocytogenes meningitis. Odio, C., Thomas, M.L., McCracken, G.H. Antimicrob. Agents Chemother. (1984) [Pubmed]
  21. Biliary elimination of mezlocillin: an experimental and clinical study. Brogard, J.M., Kopferschmitt, J., Arnaud, J.P., Dorner, M., La Villaureix, J. Antimicrob. Agents Chemother. (1980) [Pubmed]
  22. Multi-institutional study of mezlocillin therapy of urinary tract infections. Cox, C.E. J. Antimicrob. Chemother. (1982) [Pubmed]
  23. Is treatment of acute exacerbations of chronic bronchitis with intramuscular mezlocillin justifiable? Maesen, F.P., Davies, B.I., Brouwers, J., Salemans, T. J. Antimicrob. Chemother. (1983) [Pubmed]
  24. Penetration of mezlocillin into pancreatic juice. Pederzoli, P., Orcalli, F., Falconi, M., Bozzini, L., Martini, N. J. Antimicrob. Chemother. (1986) [Pubmed]
  25. Kinetics of intravenous mezlocillin in chronic hemodialysis patients. Francke, E., Mehta, S., Neu, H.C., Appel, G.B. Clin. Pharmacol. Ther. (1979) [Pubmed]
  26. Prostaglandins mediate the adrenocorticotropin response to tumor necrosis factor in rats. Sharp, B.M., Matta, S.G. Endocrinology (1993) [Pubmed]
  27. Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin. Coppens, L., Klastersky, J. Antimicrob. Agents Chemother. (1979) [Pubmed]
  28. Sulbactam and clavulanic acid: studies of enzyme kinetics and synergy with ampicillin and mezlocillin. Cullmann, W., Stieglitz, M., Opferkuch, W. Drugs (1988) [Pubmed]
  29. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line. Ferreira, M.J., Gyémánt, N., Madureira, A.M., Tanaka, M., Koós, K., Didziapetris, R., Molnár, J. Anticancer Res. (2005) [Pubmed]
  30. The inhibition of gastric mucosal lesion, oxidative stress and neutrophil-infiltration in rats by the lichen constituent diffractaic acid. Bayir, Y., Odabasoglu, F., Cakir, A., Aslan, A., Suleyman, H., Halici, M., Kazaz, C. Phytomedicine (2006) [Pubmed]
  31. Effect of interferon-gamma and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells. Wedgwood, J.F., Hatam, L., Bonagura, V.R. Cell. Immunol. (1988) [Pubmed]
  32. Immunological studies in acquired immunodeficiency syndrome: effect of TCGF and indomethacine on the in vitro lymphocyte response. Hofmann, B., Fugger, L., Ryder, L.P., Gaub, J., Odum, N., Platz, P., Gerstoft, J., Svejgaard, A. Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc. (1987) [Pubmed]
  33. An unforeseen complication of home parenteral antibiotic therapy. Burks, J.H., Fliegelman, R., Sokalski, S.J. Arch. Intern. Med. (1989) [Pubmed]
  34. Mezlocillin kinetics in hepatic insufficiency. Bunke, C.M., Aronoff, G.R., Brier, M.E., Sloan, R.S., Luft, F.C. Clin. Pharmacol. Ther. (1983) [Pubmed]
  35. Solid-phase ion-pair extraction and liquid chromatography of mezlocillin in serum. Jones, C.W., Chmel, H. Clin. Chem. (1988) [Pubmed]
 
WikiGenes - Universities